Of the two well-known rodent models of human type 1 diabetes (the non-obese diabetic mouse and the BioBreeding rat) the mouse has become the model of choice. Here the authors re-examine the value ...

Another underused model resource is the set of spontaneous ... Are there differences in the pathogenesis and response to therapy of mouse diabetes disease models with an acute onset versus those ...

distasonis peptide and that P. distasonis can enhance type 1 diabetes development in the the mouse model, we have to prove that this enhancement is directly related to the peptide,” Altindis said. To ...

Diabetes affects the body's ability to control ... labs together to perform a study with antibiotics in a diabetic mouse model of S. aureus infection. First, the team prepared a mouse model ...

The researchers also examined a mouse model of diabetes-related metabolic syndrome to investigate the potential benefit of targeting MPC in high-risk patients with metabolic disorders. Blocking MPC ...

using a preclinical mouse model that closely mimics human consumption patterns. The study, published in the Journal of ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Updated results from BP1001-A obesity and Type 2 diabetes testing from the second stage of pre-clinical testing are as follows: Previously, Bio-Path reported BP1001-A increased insulin sensitivity in ...

Diabetes affects the body’s ability to control ... labs together to perform a study with antibiotics in a diabetic mouse model of S. aureus infection. First, the team prepared a mouse model ...